Single-Agent Chemotherapy with Docetaxel Significantly Reduces PSA Levels in Patients with High-Grade Localized Prostate Cancers

Publisher： Karger

E-ISSN： 1423-0399|73|2|110-112

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.73, Iss.2, 2004-08, pp. : 110-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cisplatin as Single-Agent Chemotherapy in Patients with Liver Dysfunction Due to Metastases

By  

Oncology Research and Treatment, Vol. 32, Iss. 7, 2009-06 ,pp. : 400-404

Karger

Access to resources Recommend Favorite

Single-Agent Gemcitabine for Biliary Tract Cancers

By  

Oncology, Vol. 70, Iss. 5, 2007-01 ,pp. : 358-365

Karger

Access to resources Recommend Favorite

High neutrophil‐to‐lymphocyte ratio predicts poor clinical outcome in patients with castration‐resistant prostate cancer treated with docetaxel chemotherapy

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 9, 2015-09 ,pp. : 827-833

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nedaplatin as a Single-Agent Chemotherapy May Support Palliative Therapy for Patients with Adenoid Cystic Carcinoma: A Case Report

By  

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-08 ,pp. : 783-789

Karger

Access to resources Recommend Favorite

Editorial Comment to High neutrophil‐to‐lymphocyte ratio predicts poor clinical outcome in patients with castration‐resistant prostate cancer treated with docetaxel chemotherapy

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 9, 2015-09 ,pp. : 834-834

John Wiley & Sons Inc

Access to resources Recommend Favorite